Urofollitropin is a hormone medication used primarily in the treatment of female infertility, particularly in women whose ovaries do not produce eggs or those undergoing in vitro fertilization (IVF). Infertility is defined as the inability to conceive after one year of trying. Factors affecting ovulation, fertilization, and implantation can contribute to female infertility. Urofollitropin mimics follicle-stimulating hormone (FSH), promoting estrogen production, which stimulates egg development and follicle maturation in women facing ovulation issues. This medication plays a significant role in enhancing fertility treatment outcomes. In summary, Urofollitropin is essential for women seeking to conceive through assisted reproductive techniques.
Urofollitropin functions by stimulating the ovaries to produce eggs through its action similar to natural follicle-stimulating hormone (FSH), thereby enhancing estrogen production and promoting follicular growth.



